Sub menu

 

 

Updates to listed medicine ingredients

Updates to the Therapeutic Goods (Permissible Ingredients) Determination

Updates to listed medicine ingredients occur quarterly at minimum. Notices regarding updates to listed medicine ingredients are shown in this collection.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Type

Topics

Audiences

Read more about Changes to the Permissible Ingredients Determination.

The Therapeutic Goods (Permissible Ingredients) Determination contains the current list of permissible ingredients for listed medicines.

34 result(s) found, displaying 1 to 10

  • Update to listed medicine ingredients in December 2025

    Regulatory decision notices
    Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 4) 2025, which commenced on 10 December 2025.

  • Urolithin A

    Compositional guidelines
    Compositional guideline for Urolithin A permitted for use in listed medicines.

  • Pediococcus pentosaceus CECT 8330

    Compositional guidelines
    Compositional guideline for Pediococcus pentosaceus CECT 8330 permitted for use in listed medicines.

  • Update to listed medicine ingredients in September 2025

    Regulatory decision notices
    Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2025, which commenced on 19 September 2025.

  • Nicotinamide mononucleotide

    Compositional guidelines
    Compositional guideline for Nicotinamide mononucleotide permitted for use in listed medicines.

  • Stearoyl Glutamic Acid

    Compositional guidelines
    Compositional Guideline: Stearoyl Glutamic Acid permitted for use in listed medicines.

  • Sorbitan Distearate

    Compositional guidelines
    Compositional guideline Sorbitan Distearate permitted for use in listed medicines.

  • Update to listed medicine ingredients in June 2025

    Regulatory decision notices
    Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2025, which commenced on 20 June 2025.